Document is current
Any future updates will be listed below
-
Authors
Krückel, Annika
Gocke, Julia
Hörner, Manuel
Keller, Katharina
Müller, Carolin
Brückner, Lena
Heindl, Felix
Hack, Carolin C.
Beckmann, Matthias W.
Amann, Niklas
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 1 September 2025
Accepted: 27 November 2025
First Online: 13 January 2026
Declarations
:
: NA received honoraria for lectures and participation in advisory boards: Gilead, Georg Thieme Verlag. NA also received support for attending meetings from AstraZeneca, Novartis, Pfizer. LB received lecture fees from Gilead, as well as support for attending meetings from Lilly, Gilead and AstraZeneca. CCH received honoraria from AstraZeneca, Daiichi Sankyo, Eisai, Novartis, Pfizer, Roche, Gilead and MSD as well as support for attending meetings from Daiichi Sankyo. MH received research support from Helsinn Healthcare SA, honoraria from Lilly Deutschland GmbH and travel support from Novartis, Lilly Deutschland GmbH, and AstraZeneca. AK received lecture fees from Gilead and Novartis, honoria for written scientific work from Georg Thieme Verlag as well as support for attending meetings from Lilly. CM received honoraria for scientific work from Novartis. All other authors declare that they have no competing interests.
: An ethics committee approval was not necessary for this review article.
